Acacia's CombiMatrix signs service deal with Australian Genome Research Facility

By E. Janene Geiss

Philadelphia, Aug. 7 - Acacia Research Corp. announced Monday that its CombiMatrix group has signed a non-exclusive agreement with the Australian Genome Research Facility under the company's CombiCore access program.

Under the agreement, all of the facility's researchers can purchase CombiMatrix CustomArrays and CatalogArrays, including array processing services performed at the research facility, according to a company news release.

The facility is Australia's largest contract genomics research and services organization serving more than 2,000 researchers, officials said.

Researchers throughout Australia and New Zealand can now send their biological samples to the facility, a certified CombiCore, for array and data processing.

The research facility was established in 1997 with the mission of providing high quality genomic services to the academic and industry research sectors. It provides services covering large-scale DNA sequencing, genotyping, gene expression, methylation, nucleic acid extraction, plant growth/stress and associated bioinformatics. The company provides services to organizations spanning the entire biological and biotechnological research spectrum including biomedicine, plant and animal science, microbiology, evolutionary biology and biodiversity.

Acacia comprises two operating groups, Acacia Technologies group and CombiMatrix group. Newport Beach, Calif.-based CombiMatrix develops technology to produce customizable arrays, which are semiconductor-based tools to identify and determine the roles of genes, gene mutations and proteins.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.